Genetic Variations Identify Predisposition to Early Cardiovascular Events in Asian Populations
WALTHAM, Mass., Oct. 30 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), announced today that Kenneth Kornman, Ph.D., the company's Chief Scientific Officer, will present new research findings on the genetics of cardiovascular disease at the 11th Cardiovascular Genomics and Atherosclerosis Symposium (CVGAS), which takes place from Oct. 31 - Nov. 1, 2008, at the Samsung Medical Center in Seoul, South Korea. Dr. Kornman will present at 9:00 a.m. on Friday, Oct. 31.
Dr. Kornman will present "Inflammation genetics and cardiovascular disease," highlighting new findings on genetic differences between Caucasian and Asian populations relative to inflammatory response and cardiovascular disease.
Dr. Kornman commented, "The new genetic findings are based on a study of the genetics of early heart disease conducted in Seoul, South Korea. Genetic patterns were identified that appear to increase inflammatory responses and increase the risk for an early heart attack in Koreans. This information should be valuable in guiding the medical management of high-risk patients."
The new genetic findings are the result of research collaborations with Dr. Yangsoo Jang, Cardiovascular Genome Center and Cardiology Division at Yonsei University and Dr. Jong Ho Lee, Yonsei University Research Institute of Science for Aging. The study evaluated genetic variations involved in inflammatory responses in individuals who had a heart attack or blocked coronary arteries prior to age 56.
In addition, the study identified an IL-1 genetic pattern that appears
to protect against early onset heart disease in approximately seven percent
|SOURCE Interleukin Genetics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved